Clinical Trials Browser

Phase 2 × Advanced Gastric Cancer × Sunitinib × Clear all

NCT01238055 2013-04-09

Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer

Phase 2 Completed

Gastrointestinal

Advanced Gastric Cancer